bso glutathione inhibitor
bso glutathione inhibitor Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0% (TLC) 250 mg resistant human breast cancer cells Glutathione and Thioredoxin Antioxidant Pathways
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell D, L Buthionine (S, R) sulfoximine recapitulates the anti obesity effects of sulfur amino acid restriction without the associated deleterious effects on bone in male mice Aging Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect Scheme of sulphate assimilation and glutathione synthesis in plants. Download Scientific Diagram
USD23.37
USD56.37
Pay in 4 interest-free payments of $5.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
